In the industry's first, pharmaceutical major Glenmark has raised USD 228 million in sustainability-linked loan (SLL) from a consortium of foreign lenders, led by Bank of America.

Share Market Live

NSE

Bank of America, the sole underwriter of the entire loan, has extended USD 50 million, and Cincinnati, Ohio-based Fifth Third Bank chipped in with USD 30 million, the company said.

"We have raised an SLL of USD 228 million under the ECB (external commercial borrowing) category at a significantly lower cost to refinance its existing ECB debt. This we believe is the first SLL loan by a domestic pharmaceutical company," Glenmark Executive Director and Chief Financial Officer VS Mani told.

Also Read:

Glenmark Pharma gets tentative USFDA nod for Regadenoson injection, stock gains after fall in early trade